143655-70-3 Usage
Uses
Used in Pharmaceutical Industry:
C15H17FN2O3 is used as an antidepressant medication for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, and bulimia nervosa. It helps alleviate symptoms by modulating serotonin levels in the brain.
Used in Gynecological Applications:
Fluoxetine is used as a treatment for premenstrual dysphoric disorder, helping to manage the severe emotional and physical symptoms that occur in the luteal phase of the menstrual cycle.
Used in Off-Label Prescriptions:
Although not officially approved for these uses, C15H17FN2O3 is sometimes prescribed off-label for conditions such as anxiety and post-traumatic stress disorder, due to its effects on serotonin levels and its potential to alleviate associated symptoms.
Fluoxetine is typically administered in the form of oral capsules or liquid solution and is generally well-tolerated, with common side effects including nausea, headache, and insomnia.
Check Digit Verification of cas no
The CAS Registry Mumber 143655-70-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,6,5 and 5 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 143655-70:
(8*1)+(7*4)+(6*3)+(5*6)+(4*5)+(3*5)+(2*7)+(1*0)=133
133 % 10 = 3
So 143655-70-3 is a valid CAS Registry Number.
143655-70-3Relevant articles and documents
Intermediate for synthesizing camptothecin derivative as well as preparation method and application thereof
-
, (2020/08/09)
The invention relates to the technical field of organic compound synthesis, in particular to an intermediate for synthesizing a camptothecin derivative as well as a preparation method and applicationof the intermediate. An intermediate A can be obtained by acylation, bromination and cross coupling reaction of 3-fluoro-4-methylaniline. The intermediate A can be used for preparing an intermediate Bso as to further prepare Exatecan mesylate. The intermediate compound B can be obtained by rearrangement reaction of the intermediate A; Exatecan mesylate can be obtained by subjecting the intermediate compound B to alpha-site acetamido and amino deprotection, condensation reaction and hydrolysis reaction. The method has the advantages of low price of reaction initiators, mild reaction conditionsof each step, simplicity and convenience in operation, high yield and suitability for industrial production.
